The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Thank you Seaking, that is very helpful indeed in helping me understand the differences between Tullow and other oil companies. I'll take my time to digest everything you've said.
I was very impressed with Rahul on the most recent webinar, and have topped up a few times since my initial buy 6 months ago. Appreciate very much your comments, and often read the knowledgable comments on this board from a number of posters, and have also quickly learned who to put in the green box!
Do any of the knowledgeable investors on here know why we often seem to go up disproportionately to other oilers? Or why we sometimes go down when they go up?
I’m obviously very happy to see the rise today, but after 6 months of being in TLW, still struggling often to understand the price changes in the absence of any news.
Basically, why today and why so big an increase? When on other days when oilers have gone up we haven’t?
Sogamla - thanks for the reassuring words!
Doh - bought a few more K in my ISA at the open, thinking it would go up on the RNS news, so I paid 45. Annoying, but hoping for the best.
But then when it went down took advantage to buy some more in my SIPP for the long-long-term at 40. Hope I've done the right thing?
Just bought an extra £1K worth at 48. My previous purchases were at 16 and 27, but I still think it's worth adding more at this price. I expect within a week or two it will be back in high 50's, and if not, I am happy to hang on til end of year or longer.
I was very impressed with Rahul in the recent webinar. If I had more spare cash I would add more, and will do if we get another good buying opportunity early in the new ISA year.
Attack today - reminding myself ... didn’t someone say last week that shorters will try and close this week / next? That way they can offset loss against gains in this tax year?
Could be why we’re seeing volatility today and for the next 2 weeks? Thoughts?
Personally I prefer slow steady rises like this, rather than last week’s spike then collapse. If we could get a small-ish rise each day this week, we can easily be past £1 by Friday. Like someone else this morning, I’m also minded of the NYCT share price rise - not all instant, so hold, hold, hold.
Re: RNS, my only wish is that it had repeated the spec and sensitivity stats, as they are so good.
Sounds like a great farce for an episode of Allo Allo. Featuring the British airmen with the vaccine, whilst the French resistance and the Germans variously saying they want but simultaneously don’t want the vaccine. With the elderly undertaker collapsing at the end, under the weight of all the coffins of people who die unnecessarily after not getting the vaccine.
Deloitte £1,000 per day consultants.
Very expensive app, that other countries did for next to no money.
Serco / Sitel - useless telemarketers; people being paid to sit doing nothing
Management consultancy paid huge amounts to come up with mission and vision statements for moonshot
Need I go on???
After months of quiet, I’m awoken to the sound of school children talking excitedly as they pass my house on the main road. I’m very near to a primary school and 2 secondaries.
Lovely sound to hear, as children are finally going back to school and a bit of normality for them, and chance to see their friends.
Also a lovely sound to hear for us investors, as they all go off to get their LFT tests this week, and soon to be posted out by the millions each week.
RM did a video interview with proactive 5-6 weeks ago.
They are a small biotech without a marketing team. I imagine they are focused on what is important right now, rather than wondering if a small PI has a constant need for information.
When there is news, we will get an RNS.
Bright1232 - thanks for your thought from a GP perspective. Good to know the sort of things NICE would look at from cost/benefit analysis.
We know from RM they are looking at price tag if circa $3000, so not far off £2,300. Although I also expect NHS / NICE to negotiate hard. And UK with single buyer often get much better drug prices v in US with multiple, smaller hospital groups.
I think we also underestimate the medical and government bureaucracy involved in setting up in each new country, even with Parexel.
And I imagine in some countries there will be attempts to extort bribes in return for trial approval. So thank god we have Parexel to navigate that sort or nightmare. They will know how to do it legally without paying the bribe, and how to ensure the results are beyond question.
Bright1232 - as you’re a GP, interested in your view: assuming SNG is approved, do you see this as being used:
- primarily in hospital?
- primarily for outpatients, prescribed by GPs?
- some other mix?
- if outpatient use, do you think it would be restricted to at risk groups?
Given your knowledge on NICE and nhs budgets, what sort of price would be sustainable for outpatient use?
CityTrader - I no longer have any trust in your predictions.
- Last week you predicted with certainty on 2 separate days that a TR1 was coming, based on your knowledge / contacts. You were wrong.
- Then you are predicting 100% certainty it will be next week, and it will be American.
- And just now, you are saying it may be 1 buyer or it may be 2 buyers
- You led us to believe your predictions were based on actual knowledge of something happening. Now you are saying your prediction is based on some rough calculations with a flawed methodology, based on data that we all know is often flaky at best. And how does that tell you that the buyer is American?
On top of all that, you have made a lot of predictions in the past which have turned out to be completely unfounded. What is your game here? Pure attention-seeking, or trying to influence the price???